ENOV - Enovis Corp
Enovis Corp Logo

ENOV - Enovis Corp

https://www.enovis.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.

52W High
$49.83
52W Low
$25.47
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.79
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
9.09
EV/EBITDA (<8 favorable)
22.42
EV/Revenue (<3 favorable)
1.49
P/S (TTM) (<3 favorable)
0.84
P/B (<3 favorable)
0.71
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
1.56%
Institutions (25–75% balanced)
121.38%
Shares Outstanding
57,160,000
Float
56,426,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
2,189,576,000
Gross Profit (TTM)
1,319,945,000
EPS (TTM)
-14.95
Profit Margin (>10% good)
-0.38%
Operating Margin (TTM) (higher better)
0.02%
ROE (TTM) (>15% strong)
-0.28%
EPS YoY (Quarterly) (>10% good)
1.53
Revenue YoY (Quarterly) (>8% good)
0.08
Momentum
Bearish momentum
Value
0.6520
Previous
0.6295
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025